Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

An Interview with Expert Clinician Dr. Fred Wigley

Jason Liebowitz, MD, FACR  |  Issue: January 2024  |  January 10, 2024

During my fellowship, Mary Betty Stevens, MD, was brilliant and nurtured my career.

During my faculty years, the major (among many) mentors have been my colleague in pulmonary medicine, Robert Wise, MD, and my first postdoctoral fellow, Antony Rosen, MBChB, MS, who is a superb leader and basic scientist and a world-class clinician.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

TR: What habits can a fellow in training or junior rheumatologist incorporate into daily practice to build their skills as a clinician?

Dr. Wigley: Today, the physician is burdened not only with making sure the quality of information is good, but also with entering volumes of data into the computer. This is occurring with increasing demands for care and stress to act quickly. The time we spend with direct patient care is shrinking as we are consumed by data collection and documentation. The time with our eyes on the computer far outweighs the time we have for the patient. While there is incredible potential for integrating comprehensive, paperless information and data collected into our patient care, the technology is moving faster than the research to provide evidence that it makes a difference.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We need to recognize that escaping old ideas and methods is very hard to do and one should not get stuck in their internship mode. Rather, many old principles are essential to treasure:

  • Allow time for your senses to be used during each encounter to characterize the patient.
  • Listen carefully and focus on body language as the patient relates his or her problems.
  • Guide the patient with questions to unearth symptoms and signs.
  • Allow time for the patient to have an exam that is designed to address the problem and, yet, have a routine system to explore unexpected signs and clues.
  • Take time to stop and think, remembering your limitations and the need to consult with others and to double check plans and interventions.
  • Never accept a rumored diagnosis; convince yourself the evidence is solid (e.g., review labs, images and pathology yourself), and recognize the complex biological networks that may influence your therapy (e.g., age may influence responses).
  • Make sure you ask patients how they are coping and that they understand the plan. Our goal is not only to treat the patient’s disease, but to also improve their quality of life as they experience it.
  • Communicate carefully in an unrushed manner during the visit, but also provide ways for the patient to ask for help anytime.
  • Finally, follow up. The answer to the problem and the response to your intervention often is revealed in the chapters that unfold before you and help tell the story and solve mysteries.

TR: What lessons have you learned from patients that have contributed to your own growth as a clinician?

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionProfiles Tagged with:Dr. Fred WigleyRole Models in Rheumatology

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Targeted Therapy for Scleroderma Fibrosis

    October 11, 2016

    Scleroderma, or systemic sclerosis (SSc), is an autoimmune disease characterized by vasculopathy and fibrosis. Although relatively rare, with a prevalence in North America of approximately 300 per 1 million people, SSc is associated with significant morbidity and high rates of mortality.1 Patients with scleroderma have four times greater mortality than age- and sex-matched controls, with…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences